Cephalon Stock: Susquehanna International’s Biggest Healthcare Company Holding in Q3

Wall St. Watchdog reveals information regarding Susquehanna International Group’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 721 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $1.017 billion.

  • Cephalon Inc. (NASDAQ:CEPH): On 06/30/2011, Susquehanna International Group reported holding 565,246 shares with a market value of $45,163,156. This comprised 0.21% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 891,064 shares with a market value of $71,908,862. This comprised 0.3% of the total portfolio. The net change in shares for this position over the two quarters is 325,818. About Company: Cephalon, Inc. is an international biopharmaceutical company that discovers, develops, and markets biopharmaceutical products to treat neurological disorders, pain, and cancer. The Company’s products include a product that treats excessive daytime sleepiness associated with narcolepsy.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Susquehanna International Group reported holding 1,781,266 shares with a market value of $36,694,080. This comprised 0.17% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 3,823,241 shares with a market value of $67,594,902. This comprised 0.29% of the total portfolio. The net change in shares for this position over the two quarters is 2,041,975. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Susquehanna International Group reported holding 951,904 shares with a market value of $33,592,693. This comprised 0.15% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 1,749,639 shares with a market value of $57,213,197. This comprised 0.24% of the total portfolio. The net change in shares for this position over the two quarters is 797,735. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): On 06/30/2011, Susquehanna International Group reported holding 1,676,564 shares with a market value of $80,843,918. This comprised 0.37% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 1,466,615 shares with a market value of $54,587,412. This comprised 0.23% of the total portfolio. The net change in shares for this position over the two quarters is -209,949. About Company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, Susquehanna International Group reported holding 203,936 shares with a market value of $7,653,718. This comprised 0.04% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 1,309,311 shares with a market value of $48,405,229. This comprised 0.21% of the total portfolio. The net change in shares for this position over the two quarters is 1,105,375. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Biogen Idec Inc. (NASDAQ:BIIB): On 06/30/2011, Susquehanna International Group reported holding 234,808 shares with a market value of $25,105,671. This comprised 0.11% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 509,641 shares with a market value of $47,473,060. This comprised 0.2% of the total portfolio. The net change in shares for this position over the two quarters is 274,833. About Company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • St. Jude Medical Inc. (NYSE:STJ): On 06/30/2011, Susquehanna International Group reported holding 687,727 shares with a market value of $32,790,824. This comprised 0.15% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 872,422 shares with a market value of $31,572,951. This comprised 0.13% of the total portfolio. The net change in shares for this position over the two quarters is 184,695. About Company: St. Jude Medical, Inc. develops, manufactures, and distributes medical devices for the worldwide cardiovascular market. The Company serves patients and its health care customers with products and services including heart valves, cardiac rhythm management systems, specialty catheters, and other cardiovascular devices.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Susquehanna International Group reported holding 111,892 shares with a market value of $7,443,055. This comprised 0.03% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 451,914 shares with a market value of $28,782,402. This comprised 0.12% of the total portfolio. The net change in shares for this position over the two quarters is 340,022. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, Susquehanna International Group reported holding 291,643 shares with a market value of $22,972,718. This comprised 0.11% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 360,355 shares with a market value of $23,523,974. This comprised 0.1% of the total portfolio. The net change in shares for this position over the two quarters is 68,712. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.
  • Hca Hldgs Inc Com (NYSE:HCA): On 06/30/2011, Susquehanna International Group reported holding 67,410 shares with a market value of $2,224,530. This comprised 0.01% of the total portfolio. On 09/30/2011, Susquehanna International Group reported holding 1,136,116 shares with a market value of $22,904,098. This comprised 0.1% of the total portfolio. The net change in shares for this position over the two quarters is 1,068,706. About Company: HCA Holdings, Inc. operates hospitals. The Company operates acute care hospitals, outpatient facilities, clinics and other patient care delivery settings. HCA operates hospitals in the United States and the United Kingdom.

(Note: Data regarding Susquehanna International Group’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet